Transitioning Emotionally and Academically to Middle School Successfully (TEAMSS)
TEAMSS
2 other identifiers
interventional
32
1 country
1
Brief Summary
Excessive anxiety is a common problem that severely impairs short and long term academic functioning. The transition to middle school (MS) results in increases in anxiety and decreases in academic functioning. Students with anxiety in particular, due to their vulnerability to school-based stressors, are at risk for social, emotional and academic failure during the transition to MS. Unfortunately, the majority of these students do not get identified. Reducing student anxiety has been associated with improvement in academic functioning. Because the transition to MS is inevitable, targeting students with excessive anxiety will help their adjustment to their new school setting, reducing the need for special education and mental health counseling. No interventions exist to help these students with this transition. This study aims to: (1) develop and assess the feasibility of a brief, multi-component intervention, referred to as TEAMSS, Transitioning Emotionally and Academically to Middle School Successfully, to reduce anxiety and improve academic functioning through the transition to MS using an iterative development process (i.e., expert review, two open trials, and small randomized controlled trial (RCT)); (2) conduct a pilot RCT comparing the preliminary impact of TEAMSS, relative to enhanced usual care (EUC), in improving students' social, behavioral, and academic functioning through the transition to MS; and (3) examine theory-based mediators, predictors, and moderators of TEAMSS and assess intervention costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2021
CompletedFirst Posted
Study publicly available on registry
December 6, 2021
CompletedStudy Start
First participant enrolled
February 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
ExpectedJune 8, 2025
June 1, 2025
1.6 years
November 5, 2021
June 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Clinical Global Impression - Severity (CGI-S) Scale
The CGI-S score provides a global rating of anxiety severity ranging from 1= "not at all ill" to 7= "extremely ill".
Change from baseline (before intervention) to follow up at 8 months
Change in Clinical Global Impression - Improvement (CGI-I) Scale
The CGI-I provides a global rating of clinical improvement in anxiety (relative to baseline) ranging from 1= "very much improved" to 7= "very much worse." Scores of 1-2 are considered "responders."
Change from post intervention evaluation to follow up at 8 months
Secondary Outcomes (16)
Change in Screen for Child Anxiety Related Emotional Disorders, Child and Parent Versions (SCARED)
Change from baseline (before intervention) to follow up at 8 months
Change in Anxiety Disorders Interview Schedule for DSM-V, Parent and Child Versions (ADIS-V)
Change from baseline (before intervention) to follow up at 8 months
Change in Child Anxiety Impact Scale (CAIS)
Change from baseline (before intervention) to follow up at 8 months
Change in School Anxiety Scale - Teacher Report (SAS)
Change from baseline (before intervention) to follow up at 8 months
Change in School Records
Change from baseline (before intervention) to follow up at 8 months
- +11 more secondary outcomes
Other Outcomes (2)
Change in TEAMSS Intervention Satisfaction Questionnaire
Change from post intervention evaluation to follow up at 8 months
Change in The Child and Adolescent Services Assessment (CASA)
Change from baseline (before intervention) to follow up at 8 months
Study Arms (2)
TEAMSS Intervention in the RCT
EXPERIMENTALStudents randomly assigned to the TEAMSS intervention will receive the 5th and 6th grade components.
Enhanced Usual Care in the RCT
NO INTERVENTIONEnhanced Usual Care (EUC) will serve as the comparison group. EUC will be comprised of written materials (given all at once after randomization by study team) for parents and children that include: 1) a specialty mental health referral list; 2) a list of websites and books on child anxiety; and 3) tip sheets on successful transitions to MS. Families in this condition will not be prohibited from seeking treatment (though this will be monitored) for their children. These students will visit and meet with the 6th grade clinician in the spring of 5th grade.
Interventions
Students randomized to TEAMSS will receive reading materials on transitioning to middle school and a a school tour with the middle school clinician (in 5th grade) and the TEAMSS group sessions (in 6th grade) delivered over 10 weeks. During the 10 weeks of TEAMSS, parents of students will attend two group meetings and clinicians will consult with at least one teacher (usually the advisory/homeroom teacher).
Eligibility Criteria
You may qualify if:
- be in the last year of a participating elementary school
- have elevated anxiety symptoms that are their primary concern as indicated by 1) a total SCARED score at baseline of 15 or higher using parent and/or child report, and/or 2) a Clinician Severity Rating (CSR) of 3 or higher on the ADIS
- read and understand English (both parent and child).
You may not qualify if:
- Students who have a non-anxiety primary mental health concern (e.g., ADHD) will be excluded from TEAMSS, as this intervention is aimed at reducing anxiety and it would not be effective at treating other mental health concerns. Students with comorbid conditions secondary to anxiety will be eligible.
- Clinician:
- All clinician participants must be at least a part time employee of a CT MS in the role of school clinician.
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UConn Healthlead
Study Sites (1)
UConn Health
West Hartford, Connecticut, 06119, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Golda Ginsburg, PhD
UConn Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- independent evaluators
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 5, 2021
First Posted
December 6, 2021
Study Start
February 8, 2024
Primary Completion
August 30, 2025
Study Completion (Estimated)
July 30, 2026
Last Updated
June 8, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share